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NEW AND NOTEWORTHY (75 words):  27 
Heavy-intensity ‘priming’ exercise (PE) elicited faster pulmonary oxygen uptake (V̇O2) 28 
kinetics during moderate-intensity cycling exercise in middle-aged individuals with type 2 29 
diabetes (T2D). This was accompanied by greater near–infrared spectroscopy-derived muscle 30 
deoxygenation (i.e. deoxygenated haemoglobin and myoglobin concentration, [HHb+Mb]) 31 
responses and a reduced Δ[HHb+Mb]/ΔV̇O2 ratio. This suggests that the PE-induced 32 
acceleration in oxidative metabolism in T2D is as a result of greater O2 extraction and better 33 
matching between O2 delivery and utilisation.  34 
 35 
  36 
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Abstract 37 
The pulmonary oxygen uptake (V̇O2) kinetics during the transition to moderate-intensity 38 
exercise is slowed in individuals with type 2 diabetes (T2D), at least in part due to limitations 39 
in O2 delivery. The present study tested the hypothesis that a prior heavy-intensity warm-up 40 
or ‘priming exercise’ (PE) bout would accelerate V̇O2 kinetics in T2D, due to a better 41 
matching of O2 delivery to utilisation. Twelve middle-aged individuals with T2D and 12 42 
healthy controls (ND) completed moderate-intensity constant-load cycling bouts either 43 
without (ModA) or with (ModB) prior PE. The rate of muscle deoxygenation (i.e. 44 
deoxygenated haemoglobin and myoglobin concentration, [HHb+Mb]) and oxygenation (i.e. 45 
total oxygenation index, TOI) were continuously measured by near-infrared spectroscopy at 46 
the vastus lateralis muscle. The local matching of O2 delivery to O2 utilization was assessed 47 
by the Δ[HHb+Mb]/ΔV̇O2 ratio. Both groups demonstrated an accelerated V̇O2 kinetics 48 
response during ModB compared with ModA (T2D: 32±9 vs. 42±12 s; ND: 28±9 vs. 34±8 s), 49 
and an elevated muscle oxygenation throughout ModB, while the [HHb+Mb] amplitude was 50 
greater during ModB only in individuals with T2D. The  [HHb+Mb] kinetics remained 51 
unchanged in both groups. In T2D ModB was associated with a decrease in the ‘overshoot’ 52 
relative to steady-state in the Δ[HHb+Mb]/ΔV̇O2 ratio (1.17±0.17 vs. 1.05±0.15), while no 53 
overshoot was observed in the control group prior to (1.04±0.12) or after (1.01±0.12) PE. Our 54 
findings support a favourable priming-induced acceleration of the V̇O2 kinetics response in 55 
middle-aged individuals with uncomplicated T2D attributed to an enhanced matching of 56 
microvascular O2 delivery to utilisation. 57 
 58 
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Introduction 62 
Young and middle-aged individuals with uncomplicated type 2 diabetes (T2D) demonstrate a 63 
slowed adjustment of oxidative metabolism at the onset of moderate-intensity exercise 64 
represented by a prolonged time constant of the primary phase of oxygen uptake (V̇O2) 65 
kinetics (τV̇O2p) (3, 30, 39, 48, 49, 59). This means that individuals with T2D exhibit an 66 
increased oxygen deficit placing greater reliance on non-oxidative energy sources to sustain 67 
any given activity (26).  Clinically these findings are important because it is likely that they 68 
contribute to premature muscular fatigue (65), and reduced exercise tolerance in individuals 69 
with T2D (19), which is associated with an increased risk of cardiovascular outcomes and all-70 
cause mortality (33, 66). 71 
 72 
The aetiology of impaired V̇O2 responses in T2D is not well understood but it must relate to 73 
O2 delivery to, and/or O2 dependent metabolism within contracting muscle. In healthy active 74 
populations that present with an initial fast V̇O2 kinetics response (<~20s) during moderate-75 
intensity cycling exercise, the τV̇O2p appears to be limited by intracellular mechanisms (i.e. 76 
oxidative capacity of skeletal muscle) rather than O2 delivery (54). However, V̇O2 kinetics in 77 
young and middle-aged individuals with T2D appear to be impaired, at least in part, due to 78 
limitations in O2 delivery/supply to contracting muscle (3, 29, 32, 37, 41, 52), although 79 
defects in O2 extraction have also been observed (28, 60). For instance, Bauer et al. (3) 80 
observed reduced microvascular blood flow responses (calculated using τV̇O2p divided by 81 
near-infrared spectroscopy (NIRS)-derived quadriceps muscle deoxygenated haemoglobin 82 
and myoglobin, [HHb+Mb], responses) in individuals with T2D at the onset of moderate-83 
intensity cycling exercise, which has been attributed to a relative mismatch in muscle O2 84 
delivery to V̇O2. In addition, leg vascular conductance kinetics during calf plantar-flexion 85 
exercise are slowed (29, 41), steady-state femoral artery blood flow responses during cycling 86 
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and knee extension exercise are reduced (32, 37) and endothelium-dependent vasodilation of 87 
the resting femoral and brachial arteries is blunted (32, 43), in uncomplicated individuals 88 
with T2D, suggesting a maldistribution of active muscle blood flow in this clinical 89 
population. However, findings of reduced O2 delivery as the source of the impairment in V̇O2 90 
control in T2D are not unanimous (11, 53, 70), likely owing to varied methodology in 91 
exercise modalities, participant characteristics or animal models used.  92 
 93 
Heavy-intensity priming exercise (PE, or heavy warm-up) is an intervention that reduces 94 
τV̇O2p during subsequent moderate-intensity step transitions in older healthy individuals (12, 95 
13, 64), a population consistently demonstrating slowed τV̇O2p responses (45, 56), and in 96 
young healthy individuals that present with an initially slow V̇O2 kinetics response (9, 17, 21, 97 
22, 46). However, this is not observed in young individuals presenting initially with fast 98 
τV̇O2p responses (13, 64). These PE-induced reductions in τV̇O2p have been reported to be 99 
associated with improved local muscle oxygenation (13, 22) and/or elevated activity of the 100 
mitochondrial pyruvate dehydrogenase (PDH) complex (20, 21). However, activation of PDH 101 
prior to the onset of exercise via administration of dichloroacetate in the absence of 102 
augmented O2 delivery failed to demonstrate a faster τV̇O2p (36, 61). On the contrary, PE-103 
induced speeding of τV̇O2p was associated with a smaller NIRS-derived muscle Δ[HHb+Mb] 104 
to V̇O2 ratio (i.e. reduced Δ[HHb+Mb]/ΔV̇O2 ratio) throughout the exercise on-transient in 105 
young (46) and older (12) individuals, suggesting that the matching of microvascular O2 106 
delivery to utilisation plays a key role in limiting τV̇O2p during moderate-intensity exercise 107 
when the initial V̇O2 kinetics is slow. 108 
 109 
The present study aimed to investigate the influence of heavy-intensity PE on oxygen uptake 110 
and muscle oxygenation & deoxygenation kinetics on a subsequent moderate-intensity 111 
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submaximal exercise bout in T2D. We hypothesized that in middle-aged adults with T2D, PE 112 
would speed the V̇O2 kinetics response and reduce the Δ[HHb+Mb]/ΔV̇O2 ratio (i.e. 113 
reflecting a better matching of O2 delivery to O2 utilization) in a subsequent bout of 114 
moderate-intensity cycling exercise. To avoid the potential confounding effects of age on the 115 
T2D-related impairments on exercise tolerance, previously established in men (48, 69), we 116 
limited the age of participants to < 60 yr. 117 
 118 
Methods 119 
Participants 120 
Twelve individuals with uncomplicated T2D (7 males/5 females) and 12 healthy controls (7 121 
males/5 females) volunteered to participate in this study (Table 1). Participants in the control 122 
group (ND) were recruited from the general population, whilst participants with T2D were 123 
recruited from the Diabetes Outpatient Clinics of St. Columcille’s Hospital (Louglinstown, 124 
Co. Dublin) and St. Vincent’s University Hospital (SVUH, Dublin 4) following chart review. 125 
Four female participants were premenopausal (2 T2D and 2 ND) and six were 126 
postmenopausal (3 T2D and 3 ND). Participants were classified as untrained by self-report 127 
(≤1.5 h.week-1 of moderate-intensity exercise in the preceding 6 months), which was 128 
confirmed by the use of 5-day RT3 triaxial accelerometry (Stayhealthy Inc, CA) in a subset 129 
of participants (Table 1) (62).  All participants with T2D had a clinical history of diabetes 130 
between 2 and 10 years (mean ± SD = 5.9 ± 4.2 yrs.), were treated by oral hypoglycaemic 131 
agents and had adequately controlled HbA1c levels (<10%). None of the participants with 132 
T2D was taking insulin or beta-blockers and all participants were non-smokers (had not 133 
smoked during the 12-month period preceding the study). Two of the healthy controls were 134 
on prescriptive medications (statins, n = 2), and individuals with T2D were taking oral (n = 135 
10) and/or subcutaneous (n =2) hypoglycaemic prescription medications (metformin 136 
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monotherapy, n = 9; metformin & sulphonylurea, n = 1; glucagon-like peptide 1, n = 2). In 137 
addition, a subgroup of individuals with T2D was taking antihypertensive prescription drugs 138 
(angiotensin converting enzyme inhibitor, n = 3; angiotensin II receptor blocker, n = 2; 139 
calcium channel blocker, n = 3) and statins (n =5). All patients displayed no clinical evidence 140 
of cardiovascular disease (12-lead electrocardiogram treadmill stress test following the Bruce 141 
protocol), peripheral arterial disease (0.9 < Ankle-Brachial Index, ABI, < 1.3), kidney 142 
dysfunction (consistent urinary protein > 200 mg.dl-1) or liver dysfunction (urinary creatinine 143 
levels > 2.2 mg.dl-1). All participants provided written informed consent prior to participation. 144 
The study was approved by the Faculty of Health Sciences’ Research Ethics Committee, 145 
Trinity College Dublin, and St Vincent’s Healthcare Ethics and Medical Research 146 
Committee, and conducted in accordance with the principles outlined by the Declaration of 147 
Helsinki. 148 
 149 
Study Protocol 150 
Overview. Following the satisfactory completion of the 12-lead ECG stress test, all 151 
participants completed two visits to the laboratory. The controls undertook these tests in the 152 
cardiovascular performance laboratory in the Department of Physiology, Trinity College 153 
Dublin; whilst individuals with T2D did so in the exercise testing facility in St. Columcille’s 154 
Hospital. All exercise tests were carried out in an upright position on an electrically braked 155 
cycle ergometer (Excalibur Sport; Lode B.V., Groningen, Netherlands). All participants were 156 
asked to refrain from consuming alcohol, caffeine and non-prescribed nutritional supplements 157 
as well as avoiding any strenuous exercise in the 24 hours prior to testing. All premenopausal 158 
participants were tested during the mid-follicular phase (days 5-12) of the menstrual cycle. 159 
 160 
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Visit 1: Ramp incremental cycling test to exhaustion. In the first visit all participants 161 
performed a ramp incremental (RI) cycling test to exhaustion to determine V̇O2peak. The test 162 
started with an initial workload of 10 W for 2 min (i.e. ‘unloaded’ cycling). This was 163 
followed by 10/15 W.min-1 increments in power output in women (n=2/8) or 15/20/25 164 
W.min-1 increments in men (n=5/8/1) based on participants’ activity levels. Pedalling rate 165 
was held constant at an individually selected cadence between 60-75 revolutions per minute 166 
(rpm) and was maintained throughout all further testing. Failure in a test was determined as a 167 
drop in cadence exceeding 10 rpm for >5 s. Peak workload was determined according to the 168 
point of termination of the test. V̇O2peak was determined by identifying the highest 15-s mean 169 
V̇O2 value recorded before the participant’s volitional termination of the test. The first 170 
ventilatory threshold (VT) was determined as the V̇O2 at which V̇E/V̇O2 exhibited a 171 
systematic exponential increase without a concomitant increase in V̇E/V̇CO2 (67) and the 172 
deflection point of V̇CO2 vs. V̇O2 (V-slope method) during the RI test (1, 4). The first visit 173 
lasted ~45-60 min. 174 
 175 
Visit 2: Priming effect on moderate-intensity cycling exercise. In the second visit all 176 
participants performed four bouts of constant-load moderate-intensity cycling at 80% of each 177 
participant’s VT obtained during the ramp incremental test. Two of these constant-load bouts 178 
were completed without prior PE (Mod A) and two bouts were undertaken preceded by a 179 
heavy- intensity PE bout (Mod B) at an intensity of 50% delta (Δ50%; the sum of the power 180 
output at VT and 50% of the difference between the power output at VT and V̇O2peak). The 181 
order of these bouts was fixed for all participants (Fig 1). The duration of each step transition 182 
was 6 min and each transition was preceded by a 3 min ‘baseline’ cycling period at 10W. 183 
There was a 12 min rest period between each of the cycling bouts, except following the first 184 
primed moderate-intensity bout (Mod B) where participants remained seated in a chair for 45 185 
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min. This resting period has been shown to be sufficient for physiological parameters to 186 
return to baseline levels, and therefore, not to influence V̇O2 kinetics responses during 187 
subsequent exercise (8). Heart rate (HR), gas exchange/ventilatory variables and muscle 188 
oxygenation & deoxygenation were continuously measured during each cycling bout. The 189 
second visit lasted ~3 hours. 190 
 191 
Measurements 192 
During exercise, participants wore a facemask to continuously collect expired air using an 193 
online metabolic system (Innocor, Innovision A/S, Odense, Denmark) that measured airflow 194 
using a pneumotachometer. Carbon dioxide analysis was performed by using a photoacoustic 195 
gas analyzer and oxygen was analyzed using an oxygen sensor (Oxigraf Inc., USA) based on 196 
the principle of laser diode absorption spectroscopy. The volume was calibrated with a 3-litre 197 
syringe, and the oxygen sensor was calibrated (against room air) prior to each test by the 198 
researcher. Both the oxygen sensor and photoacoustic gas analyser require multi-point 199 
calibration performed by the manufacturer periodically (6-12 months). Analysis of expired air 200 
allowed determination of pulmonary O2 uptake (V̇O2), CO2 output (V̇CO2), minute 201 
ventilation (V̇E) and the respiratory exchange ratio (RER) breath-by-breath. HR was recorded 202 
every 5 s (Polar S610i, Polar Ltd, Finland), with peak HR defined as the highest HR attained 203 
within the last 15 s of the point of termination of the test. 204 
 205 
A continuous wave NIRS system (Hamamatsu Niro 200Nx; Hamamatsu Photonics, 206 
Hamamatsu, Japan), was used to determine a muscle’s oxygenation status non-invasively 207 
through the spatially resolved spectroscopy (SRS) technique and modified Beer-Lambert 208 
(MBL) principle with three wavelengths of emitting light (λ = 735, 810, and 850 nm). The 209 
theoretical basis of NIRS and its use in exercise measurements have been described in detail 210 
 10
elsewhere (14) but briefly, this technique estimates the optical density changes of oxygenated 211 
(O2Hb+Mb) and deoxygenated haemoglobin and myoglobin (HHb+Mb) based on the oxygen 212 
dependency of absorption changes for near-infrared light in these proteins. As the vastus 213 
lateralis (VL) muscle is a dominant locomotor muscle during cycling (38, 50), the present 214 
study examined the deoxy (Δ[HHb+Mb]) and tissue oxygenation index (TOI) profiles of the 215 
right quadriceps’s vastus lateralis (VL) muscle. After shaving, cleaning and drying the skin, 216 
the probes were placed on the belly of the muscle, (5-8 cm above the lateral femoral 217 
condyle), parallel to the major axis of the thigh with a 3 cm spacing between the emitter and 218 
receiver. The probes were housed in a black rubber holder and secured on the skin surface 219 
with bi-adhesive tape and then covered with a dark elastic bandage, which minimised 220 
extraneous movement and the intrusion of stray light throughout the exercise protocol. Since 221 
the depth of the measured area was estimated to be approximately one-half the distance 222 
between the emitter and the receiver (~1.5 cm), the present study determined the thickness of 223 
the skin and adipose tissue at the site of the probe placement via 2D ultrasound operating in 224 
B-mode (Zonare Ultra Smart Cart, Software version 4.7, USA), to ensure that data largely 225 
represented absorption of near-infrared light in muscle tissue and not in subcutaneous fat. An 226 
exclusion criterion applied to individuals presenting with adiposity >1.5 cm over the site of 227 
interrogation on the vastus lateralis. 228 
 229 
Data analysis 230 
V̇O2 Kinetics: The breath-by-breath V̇O2 data for each transition were linearly interpolated to 231 
provide second-by-second values and time aligned such that time 0 represented the onset of 232 
exercise. Data from each transition were ensemble-averaged to yield a single, average 233 
response for each individual and further time-averaged into 5 s bins. Nine responses (from 6 234 
participants) revealed a small slow component (Mod A: 3 T2D, 3 ND; Mod B: 2 T2D, 1 ND) 235 
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suggesting that the power outputs in these participants (3 participants showed a SC in both 236 
conditions, and 3 participans only during Mod A) were above their VT. This was likely due 237 
to the fact that in the present study the mean response times of V̇O2 during the ramp cycle 238 
exercise were not accounted for when calculating the target power outputs (27). Thus, the 239 
averaged and smoothed response for each participant was fitted to a monoexponential 240 
function (equation 1) or biexponential function (equation 2) as follows: 241 
Equation 1   V̇O2(t) = V̇O2 baseline + Ap[1-e - (t-TDp)/τp)].F1 242 
Equation 2  V̇O2(t) = V̇O2 baseline + Ap[1-e- (t-TDp)/τp)].F1 + As[1 – e -(t – TDs)/τs)].F2   243 
 244 
where V̇O2(t) represents the absolute V̇O2 at a given time t; V̇O2 baseline is the mean V̇O2 in 245 
the final 30 s of unloaded cycling; Ap – As, are the amplitudes of the increase in V̇O2 of the 246 
primary and slow component phases respectively; TDp – TDs are the phase delays, and τp – τs 247 
are the time constants, defined as the duration of time for which V̇O2 increases to a value 248 
equivalent to 63% of the amplitude. The conditional expressions F1-F2 limit the fitting of the 249 
phase to the period at and beyond the time delay associated with that phase. The first 20 s of 250 
data after the onset of exercise (i.e., the phase I V̇O2 response) were deleted, and while still 251 
allowing TD to vary freely (to optimize accuracy of parameter estimates), V̇O2 data were 252 
modelled from 20 s to 360 s of the step transition to ensure that each subject had attained a 253 
V̇O2 steady state (47). So, in this approach the TD is not used as a proxy for, nor is it 254 
synonymous with, phase I duration (47). The V̇O2 data were fitted to equation 1 or 2 using a 255 
weighted least-squares non-linear regression procedure (TableCurve 2D, Systat, USA). Data 256 
points lying outside the 95% prediction interval during the initial fit of a model were 257 
excluded. Parameter estimates of the best-fit function were used and only estimates 258 
representing the primary phase are presented. Whilst the presence of a slow component was 259 
detected in 9 responses, the presence of this phase does not appear to significantly affect the 260 
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parameter estimates of the earlier phases (68). The end-exercise V̇O2 response, referred to as 261 
End A, was calculated as the averaged V̇O2 over the last 30 s of the primary V̇O2 response.  262 
The functional “gain” of the primary V̇O2 response was calculated as the difference between 263 
End A and V̇O2 baseline normalized to the difference in power outputs between the 264 
moderate-intensity exercise and unloaded cycling. 265 
 266 
Deoxygenated haemoglobin/myoglobin [HHb+Mb] and tissue oxygenation index (TOI) 267 
kinetics. To provide information on muscle deoxygenation throughout the protocol, we 268 
modelled the [HHb+Mb] and TOI response to exercise.  As per the V̇O2 data, the NIRS-269 
derived Δ[HHb+Mb] and TOI data for each transition were linearly interpolated to provide 270 
second-by-second values and time aligned. Data from each transition were ensemble-271 
averaged to yield a single average response for each individual, and further time-averaged 272 
into 5 s bins. A time delay (TD) at the onset of exercise occurs in the [HHb+Mb] and TOI 273 
profiles before they increase and decrease, respectively. [HHb+Mb] data were fitted from the 274 
end of the TD to 180 s using equation 1 as per V̇O2. The TOI data were fitted from the end of 275 
the TD to the lowest steady state within the first 180 s of exercise also using equation 1. The 276 
shorter fitting window of 180 s was selected to counteract the reported variations in the NIRS 277 
signal, which typically present between 180-240 s from exercise onset, from impacting the 278 
fitting of the on-transient response whilst permitting the reaching of a steady-state (15, 16, 279 
46). The time course for the increase in Δ[HHb+Mb] and decrease in TOI can be described 280 
by the τΔ[HHb+Mb] and τTOI, however, the time course for the overall change of the 281 
Δ[HHb+Mb] and TOI responses, referred to as the effective response time (τ'Δ[HHb+Mb] 282 
and τ'TOI), was determined from the sum of the time delay and τ from the onset of exercise 283 
for each variable.  284 
 285 
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Δ[HHb+Mb]/ΔV̇O2 ratio. To calculate the Δ[HHb+Mb]/ΔV̇O2 ratio (44, 46) individual 286 
second-by-second Δ[HHb+Mb] and V̇O2 data were firstly normalised (from 0%, 287 
corresponding to the pre-transition 10W baseline value to 100% reflecting the post-transition 288 
steady-state response). Then, Δ[HHb+Mb] and V̇O2 were time aligned by left-shifting the 289 
normalised V̇O2 data by 20 s, accounting for the approximate duration of the cardiodynamic 290 
phase, to ensure that the onset of exercise coincided with the beginning of the primary phase 291 
of V̇O2. The normalised and time aligned data was then further averaged into 5 s bins for 292 
statistical comparisons. The overall Δ[HHb+Mb]/ΔV̇O2 ratio for the adjustment during the 293 
exercise on-transient was derived for each individual as the mean value from 20-120 s into 294 
the transition. The commencement point of 20 s was selected as it is representative of the 295 
region where the Δ[HHb+Mb] and V̇O2 signals meet, with the 120 s end point indicative of 296 
the time point at which a steady-state value of 1.0 had been achieved by the 297 
Δ[HHb+Mb]/ΔV̇O2 ratio (46). Values > 1.0 represent a time period whereby during the 298 
exercise transition there was a greater reliance on fractional O2 extraction compared with the 299 
exercise steady-state (values = 1.0), thus reflecting a poorer local O2 delivery relative to 300 
muscle O2 utilisation in the area of NIRS interrogation. 301 
 302 
Statistical analysis 303 
Statistical analysis was performed using SPSS for Windows (version 22.0, Chicago, IL). 304 
Prior to analysis, normal distribution was assessed using the Shapiro-Wilk’s test. Physical 305 
characteristics between groups were compared using the unpaired Student’s t-test for 306 
parametric analyses, or the Mann-Whitney U test for non-parametric analyses. Based on a 307 
priori evidence on the pre-determined reduced functional exercise capacity in individuals 308 
with an uncomplicated T2D, the peak physiological responses between groups were 309 
compared using unpaired 1-tailed Student’s t-test for parametric analyses, or the Mann-310 
 14
Whitney U test for non-parametric analyses.  The Δ[HHb+Mb]/ΔV̇O2 ratio and kinetics 311 
parameter estimates for V̇O2, [HHb+Mb] and TOI during moderate-intensity exercise were 312 
analysed by using a two-way [Condition (Mod A, Mod B) x diabetes status (T2D, ND)] 313 
mixed model ANOVA. To assess whether the Δ[HHb+Mb]/ΔV̇O2 ratio was different from 1 314 
(i.e. to identify if there was a mismatch between local O2 delivery relative to muscle O2 315 
utilisation) a Student’s t-test was used. Finally, correlations between changes from Mod A to 316 
Mod B in τV̇O2p and changes in Δ[HHb+Mb]/ΔV̇O2 ratios were established using the Pearson 317 
product-moment correlation coefficient (Pearson r). Statistical significance was accepted as P 318 
≤ 0.05. All values are expressed as means ± standard deviation (SD) or as median and 319 
interquartile ranges for data that were deemed not normally distributed. 320 
 321 
Results 322 
Physical characteristics and activity levels. 323 
Participants’ physical characteristics are presented in Table 1. Both groups were well 324 
matched according to sex, age, body mass and BMI. Individuals with T2D recorded lower 325 
inactivity levels and higher light-intensity activity levels than controls. As expected, 326 
participants with T2D displayed higher HbA1c and fasting plasma glucose levels. They also 327 
had higher total cholesterol and triglycerides than controls. 328 
 329 
Performance data from ramp incremental cycling test 330 
Absolute V̇O2peak (T2D: 1.97 ± 0.60 L.min-1; ND: 2.35 ± 0.50 L.min-1; P = 0.048), V̇O2peak 331 
normalised to body mass (T2D: 21.4 ± 4.1 mL.kg-1.min-1; ND: 27.6 ± 6.0 mL.kg-1.min-1; P < 332 
0.01) and peak PO (T2D: 151± 46 W; ND: 188 ± 46 W; P = 0.029) were significantly 333 
reduced in individuals with T2D compared with healthy controls.  334 
 335 
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V̇O2 kinetics 336 
The parameter estimates of the V̇O2 response to Mod A and Mod B are presented in Table 2, 337 
and responses for representative individuals are shown in Fig 2. Priming exercise (PE) 338 
resulted in an elevated V̇O2 baseline (P = 0.004) and a faster τV̇O2p (P = <0.001) in both 339 
groups. There was an interactive effect of diabetes and priming on V̇O2 A (P = 0.022), V̇O2 340 
end A (P = 0.043) and V̇O2 gain (P = 0.041), so that V̇O2 A and V̇O2 gain were lower during 341 
Mod B in T2D, but V̇O2 A and V̇O2 gain were higher in Mod B in the control group.  342 
 343 
Muscle deoxygenation kinetics, total oxygenation index and Δ[HHb+Mb]/ΔV̇O2 ratio index 344 
Kinetics parameters for Δ[HHb+Mb] and TOI responses, as well as Δ[HHb+Mb]/ΔV̇O2 ratios 345 
are displayed in Table 3, while the normalised adaptation of Δ[HHb+Mb] and V̇O2 and the 346 
corresponding Δ[HHb+Mb]/ΔV̇O2 index responses for representative individuals at the onset 347 
of exercise are shown in Fig 3. Due to a technical error with the NIRS responses data from 1 348 
participant with T2D were excluded from the analyses. There was a diabetes status x 349 
condition interaction for Δ[HHb+Mb] A (P = 0.037) so that Mod B was higher than Mod A 350 
(P = 0.041) in participants with T2D but not in controls. PE did not influence any other 351 
Δ[HHb+Mb] kinetics parameters. The TOI baseline was higher during Mod B in both groups 352 
(main effect, condition, P = 0.001) and it was higher in the control than T2D group (main 353 
effect, diabetes status, P = 0.005). PE also resulted in an elevated TOI A (P = 0.006) in both 354 
groups.  No other TOI kinetics parameters were influenced by PE. The overall 355 
Δ[HHb+Mb]/ΔV̇O2 ratio displayed tendencies for main effects on condition  (P = 0.067) and 356 
diabetes status (P = 0.060) without a condition x diabetes status interaction  (P = 0.221) 357 
(Table 3). Individuals with T2D exhibited a mismatch between local O2 delivery relative to 358 
muscle O2 utilisation (i.e. Δ[HHb+Mb]/ΔV̇O2 ratio ≠ 1) during Mod A (P = 0.007) but not 359 
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Mod B (P = 0.225). In contrast, no differences were present in controls during Mod A (P = 360 
0.291) and Mod B (P = 0.697).  361 
 362 
Correlations 363 
Changes in τV̇O2p from Mod A to Mod B and changes in Δ[HHb+Mb]/ΔV̇O2 ratios were 364 
significantly correlated in T2D (r = 0.75, P = 0.012) but not in controls (r = 0.46, P = 0.128). 365 
When all study participants were included in the analysis, these variables were significantly 366 
correlated (r = 0.72, P = <0.001).  367 
 368 
Discussion 369 
To our knowledge this is the first study investigating the effect of PE on the temporal 370 
relationship between the adaptation of muscle O2 consumption and delivery during the on-371 
transient of a subsequent bout of moderate-intensity cycling exercise in T2D. Consistent with 372 
our hypothesis, PE reduced the time of adjustment of the primary phase of the V̇O2 kinetics 373 
and this reduction was accompanied by the elimination of the “overshoot” in the 374 
Δ[HHb+Mb]/ΔV̇O2 ratio, suggesting a better matching of microvascular O2 delivery to 375 
utilisation in participants with T2D. 376 
 377 
Even if in the present study maximal oxygen uptake (V̇O2max) responses (55) were not 378 
assessed, the lower V̇O2peak responses (18) in individuals with T2D compared with healthy 379 
controls observed herein are consistent with previously reported impairments in V̇O2peak or 380 
V̇O2max in adults with T2D (2, 39, 48, 49, 59). Likewise, in the present study, τV̇O2p estimates 381 
during transition to Mod A in the group with T2D (~42 s) were similar to these reported 382 
previously in individuals with this clinical condition (~39-45 s) (19), and despite not reaching 383 
significance, the magnitude of the difference in the τV̇O2p between the T2D and healthy 384 
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control groups (i.e. ~8 s or ~20% slower) is consistent with previous research supporting 385 
impaired V̇O2 kinetics in young and middle-aged adults with T2D compared with age and 386 
BMI-matched controls (3, 30, 39, 48, 49, 58). Similarly, the PE-induced faster adaptation of 387 
τV̇O2p during the on-transition to moderate-intensity exercise in healthy controls (initial 388 
τV̇O2p: 34 s) is consistent with the literature surrounding PE in young healthy adults 389 
presenting with slow τV̇O2p and older adults (12, 20, 64). Moreover, the present study 390 
demonstrates for the first time that such PE-induced effect is also present in individuals with 391 
uncomplicated T2D.   392 
 393 
In the present study the NIRS-derived TOI signal was accepted as surrogate for oxygen 394 
availability within the examined vastus lateralis muscle.  Despite the demonstration of a PE-395 
induced reduction in the τV̇O2p, the dynamic response of TOI was similar in both exercise 396 
conditions for both groups. However, PE increased the resting (i.e. TOI baseline) as well as 397 
exercising (i.e. TOI amplitude) microvascular O2 availability throughout Mod B in both 398 
groups. These findings are consistent with Gurd et al. (20) who showed elevated NIRS-399 
derived changes in total [Hb+Mb] during moderate-intensity exercise subsequent to PE in 400 
older participants and suggest a greater muscle perfusion prior to and during Mod B.  401 
 402 
The changes in the NIRS-derived [HHb+Mb] are indicative of the balance between O2 403 
availability and utilisation in the microvasculature within the region of NIRS interrogation, 404 
and thus, were accepted as a surrogate for fractional O2 extraction.  In agreement with 405 
previous studies on older adults (12, 20), the overall dynamic response of muscle 406 
deoxygenation (τ'Δ[HHb+Mb]) herein was not affected by PE in both groups. In combination 407 
with an accelerated τV̇O2p, this means a greater muscle blood flow and O2 delivery to muscle 408 
O2 demand during the transition to ModB, although the role of these changes in the 409 
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enhancement of V̇O2 kinetics is not that clear. Thus, to better elucidate this, we examined the 410 
Δ[HHb+Mb]/ΔV̇O2 ratio, an index indicative of the degree of O2 extraction required for a 411 
given increment in V̇O2 (12, 44, 46). We observed that only individuals with T2D displayed 412 
an overshoot (relative to the steady-state ratio of 1.0) in the unprimed condition. This 413 
overshoot was abolished by the prior bout of heavy-intensity PE in the subsequent bout of 414 
submaximal exercise, owing to a significant reduction in the τV̇O2p (which was indeed 415 
correlated with changes in the Δ[HHb+Mb]/ΔV̇O2 ratio) and unchanged τ'Δ[HHb+Mb]. This 416 
thereby strengthened the notion that following an acute priming intervention, a reduction in 417 
the time constant of the V̇O2 kinetics response in middle-aged individuals with 418 
uncomplicated T2D is attributed to a better matching of microvascular O2 delivery to 419 
utilisation. It should be noted that even if the Δ[HHb+Mb]/ΔV̇O2 ratio for the control 420 
participants was not significantly different from the steady-state ratio of 1.0, it was 421 
numerically larger (1.04) and it was reduced following PE (1.01). As such, these results 422 
partially support previous findings by Murias et al. (46) who reported PE-induced significant 423 
reductions in the Δ[HHb+Mb]/ΔV̇O2 ratio during moderate-intensity exercise bouts 424 
(unprimed bout: 1.08 ± 0.09; primed bout: 1.01 ± 0.06) in untrained healthy participants. 425 
 426 
The present finding of a reduced O2 availability imposing a limitation to V̇O2 kinetics in 427 
middle-aged individuals with T2D (enhanced with PE) is consistent with previous 428 
observations by Bauer et al. (3) whereby blunted microvascular blood flow responses upon 429 
initiation of a moderate-intensity cycle exercise were reported accompanied with slowed  430 
τV̇O2p responses (43 s) in individuals with uncomplicated T2D. Similarly, blunted (i.e. 431 
slower) dynamic blood flow responses during intermittent calf plantar-flexion contractions in 432 
men and women with T2D (29, 41) or a transient lowering of capillary PO2 responses at the 433 
onset of exercise, thereby limiting O2 transport from the capillary to the myocyte in rodent 434 
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models with T2D (5) have also been reported. Thus, the present study extends the findings of 435 
reduced O2 delivery as a contributing factor for the impairment in the control of oxidative 436 
metabolism in T2D observed in isolated muscle groups to that of whole body exercise 437 
modalities. The mechanisms underlying the PE-induced enhancement of the dynamic blood 438 
flow response in active muscles in T2D remain unclear. It is likely, as proposed by Gerbino et 439 
al. (17) that this enhanced O2 delivery is, at least in part, mediated by a PE-induced increased 440 
lactic acidosis, via a greater perfusion and increased O2 availability through a rightward shift 441 
of the oxyhaemoglobin dissociation curve. This may help explain the greater muscle 442 
deoxygenation (Δ[HHb+Mb] amplitude) during ModB in participants with T2D, suggestive 443 
of an increase in local O2 utilization (extraction) following prior heavy-intensity PE. In 444 
addition, improvements in endothelium- and flow-mediated vasodilation responses have also 445 
been observed following an acute exercise bout, potentially enhancing O2 delivery to active 446 
muscles (23). However, the PE-augmented oxidative phosphorylation may also be related to a 447 
combination of enhanced muscle perfusion and O2 delivery with the upregulation of rate-448 
limiting mitochondrial oxidative enzymes (20, 21).    449 
 450 
Limitations  451 
The inclusion of pre- and post-menopausal women should be acknowledged as whilst the 452 
magnitude of impairments in V̇O2 does not appear to be affected by menopausal status (30), 453 
the same is unknown for muscle oxygenation & deoxygenation. In an attempt to minimise 454 
this our study matched groups on this characteristic (pre-menopausal: 2 T2D and 2 ND vs. 455 
post-menopausal: 3 T2D and 3 ND). We also acknowledge functional limitations pertaining 456 
to the NIRS technology utilised herein. Firstly, only one superficial muscle was investigated, 457 
thus interpretation of NIRS-derived data is limited to the examined region. Secondly, the 458 
established heterogeneity extant within a single muscle in terms of vascularity and fibre type 459 
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(25), fibre recruitment, vascular control and blood flow (5, 35, 42), likely extends to the 460 
vastus lateralis herein. In addition, identified variances both, between muscles (specifically 461 
vastus lateralis and rectus femoris) and between deep and superficial segments within a 462 
muscle (particularly rectus femoris) during constant load cycling need to be acknowledged 463 
(10, 34, 51, 57, 63), although this appears not to be the case between the distal and proximal 464 
portions of the vastus lateralis during ramp incremental exercise (6, 31). Thirdly, we did not 465 
correct for adipose tissue thickness at the site of measurement. However, the thickness of the 466 
skin and adipose tissue measured at the site of the interrogation via B-mode 2D ultrasound 467 
were not different between groups. Finally, the present findings are limited to middle-aged 468 
participants, so future studies should examine other populations (i.e. older adults).    469 
 470 
Perspectives and Significance 471 
This study demonstrated that a single heavy-intensity warm-up or priming exercise bout 472 
elicits a faster adaptation of the V̇O2 kinetics response in middle-aged individuals with 473 
uncomplicated T2D, by way of enhancing blood flow distribution at the level of the muscle 474 
microvasculature and better matching O2 delivery to utilisation. Such favourable 475 
manipulation of the V̇O2 kinetics response via heavy-intensity priming exercise in diabetes is 476 
promising, given that a faster provision of aerobic metabolism reduces muscle fatigue during 477 
light-, moderate-intensity transitions carried out during routine everyday tasks (7, 40). This is 478 
important given that individuals with T2D perceive light to moderate exercise as being more 479 
difficult than healthy counterparts (24). Thus, exercise training interventions designed to 480 
benefit V̇O2 control and functional independence in T2D should also focus on microvascular 481 
O2 delivery. Moreover, exercise training protocols should incorporate heavy-intensity warm-482 
up exercise to maximise the oxidative capacity of muscles and increase the effectiveness of 483 
the therapeutic effect of exercise in this all too prevalent condition.  484 
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Figure captions 707 
 708 
Figure 1 Schematic representation of the protocol. Cycling exercise at moderate-intensity 709 
without priming (Mod A) and with priming (Mod B), performed at a power output 710 
corresponding to 80% of each participant’s first ventilatory threshold (VT). Priming exercise 711 
(PE) consisted of a high-intensity cycling exercise (Δ50%; the sum of the power output at VT 712 
and 50% of the difference between the power output at VT and V̇O2peak). All step transitions, 713 
each lasting 6 min, were preceded by 3 min of cycling at 10 W (i.e. ‘baseline’ cycling). Mod 714 
A and PE step transitions were followed by 12 min of passive rest. The 3 step transitions 715 
(Mod A, PE and Mod B) were repeated following 45 min of passive rest within the same 716 
laboratory visit.  717 
 718 
Figure 2. Oxygen uptake (V̇O2) responses for a representative individual with type 2 diabetes 719 
(A) and a healthy control (B) during moderate-intensity cycling transitions without priming 720 
exercise (Mod A, open circles) and with priming exercise (Mod B, solid circles). The 721 
continuous lines of best fit (black for Mod A; grey for Mod B) illustrate the primary phase of 722 
the oxygen uptake (V̇O2) response. Note the relatively slower response of the primary phase 723 
of the V̇O2 response in the unprimed compared with the primed bouts.  724 
 725 
Figure 3. Normalised τ'Δ[HHb+Mb] (solid circles, panels A, B, D & E) and V̇O2 adjustment 726 
(open circles, panels A, B, D & E) at the onset of moderate-intensity cycling transitions for a 727 
representative individual with type 2 diabetes (panel A, Mod A; panel B, Mod B) and a 728 
healthy control (panel D, Mod A; panel E, Mod B). Profiles of the Δ[HHb+Mb]/ΔV̇O2 index 729 
are shown in panels C (individuals with T2D) and F (healthy control) where the cycling 730 
 32
transitions without priming exercise (Mod A open circles) and with priming exercise (Mod B, 731 
solid circles) are plotted as a function of time.  732 
 733 
Figure 4: Relationships between changes in τV̇O2 (%) from Mod A to Mod B and changes in 734 
Δ[HHb+Mb]/ΔV̇O2  ratio (%) in participants with T2D and ND controls.   735 
 736 
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Table 1. Physical characteristics and activity levels. 
 ND T2D P value 
n 12 12  
Physical characteristics  
   Sex (male, female) 7, 5 7, 5  
   Age (yr) 44 ± 9 48 ± 9 0.23 
   Stature (m) 1.68 ± 0.07 1.69 ± 0.08 0.85 
   BMI (kg.m-2) 30.4 ± 4.1 32.1 ± 5.6 0.35 
   Body Mass (kg) 86.0 ± 12.0 91.7 ± 18.6 0.38 
   Fat layer VL (mm)a 8.3 ± 4.5 6.5 ± 1.7 0.21 
   HbA1c (%)b 5.1 (0.5)* 6.8 (1.4) <0.001 
   FPG (mmol.L-1)c 4.0 (0.7)* 7.3 (4.1) <0.001 
   Time since diagnosis (yr)  5.9 ± 4.2  
   Total cholesterol (mmol.L-1)d 3.4 (1.6)* 4.7 (1.2) 0.03 
   LDL-C (mmol.L-1)e 1.6 ± 1.3 2.3 ± 1.3 0.11 
   HDL-C (mmol.L-1)e 1.3 ± 0.3 1.2 ± 0.2 0.26 
   Triglycerides (mmol.L-1)e 1.1 (2.5)* 1.8 (0.7) 0.03 
Habitual physical activity    
   Inactive (h.day-1)f  19.2 ± 1.2* 17.8 ± 0.8 0.05 
   Light (h.day-1)f 4.3 ± 1.1* 6.0 ± 2.0 0.05 
   Moderate (h.day-1)f 0.6 ± 0.4 0.7 ± 0.6 0.95 
   Vigorous (h.day-1)f 0.2 (0.3) 0.1 (0.2) 0.35 
 
Mean ± SD values are shown in normal font for variables which were 
normally distributed; whereas median (and interquartile range) values are 
shown in italic font for variables which showed significant skewness and were 
not normally distributed in one or both groups. n, no. of participants; BMI, 
body mass index; HbA1c, glycosylated haemoglobin; FPG, fasting plasma 
glucose; VL, vastus lateralis; LDL-C, low-density lipoprotein cholesterol; 
HDL-C, high-density lipoprotein cholesterol. Some variables have missing 
values and the sample sizes with codes are shown below. *Significantly 
different than T2D (P ≤ 0.05).  
a = 12 (ND) and 10 (T2D); b = 7 (ND) and 11 (T2D); c = 9 (ND) and 10 (T2D); 
d=8 (ND) and 9 (T2D); e = 9 (ND) and 7 (T2D); f = 9 (ND) and 5 (T2D). 
 
Table 2. Dynamic response characteristics of oxygen uptake (V̇O2). 
 Mod A Mod B 
Controls 
Type 2 
diabetes Controls 
Type 2 
diabetes 
n 12 12 12 12 
Baseline V̇O2, L/min-1  0.78 ± 0.10 0.91 ± 0.25 0.82 ± 0.10* 0.98 ± 0.23* 
V̇O2 A, L/min-1  0.68 ± 0.31 0.55 ± 0.25 0.72 ± 0.35 0.50 ± 0.20* 
V̇O2 end A, L/min-1 1.46 ± 0.35 1.46 ± 0.42 1.54 ± 0.39* 1.48 ± 0.39 
V̇O2 τ, s  33.5 ± 7.4 42.1 ± 12.2 28.3 ± 8.7* 32.2 ± 9.1* 
V̇O2 gain, mL.min-1.W-1  9.3 ± 2.1 9.4 ± 2.3 9.9 ± 2.1* 8.6 ± 1.3 
Values are means ± SD; n, no. of participants. A, amplitude; τ, time constant; end A, 
steady-state V̇O2 response.  
* P < 0.05 vs. Mod A within same diabetes status group (i.e. within controls or within 
Type 2 diabetes). † P < 0.05 vs. participants with type 2 diabetes within same 
condition (i.e. within Mod A or Mod B). 
 
Table 3 Dynamic response characteristics Δ[HHb+Mb] & TOI, and 
Δ[HHb+Mb]/ΔV̇O2 ratio index 
 Mod A Mod B 
 Controls 
Type 2 
diabetes Controls 
Type 2 
diabetes 
n 12 11 12 11 
Baseline Δ[HHb+Mb], 
μMol*cm -68.8 ± 45.2† -15.0 ± 40.8 -43.1 ± 65.6† 5.2 ± 56.0 
Δ[HHb+Mb] A, 
μMol*cm  57.4 ± 48.0 92.6 ± 61.7 57.7 ± 43.1 112.2 ± 63.4* 
Δ[HHb+Mb] τ, s 14 ± 7 15 ± 8 18 ± 7 16 ± 6 
Δ[HHb+Mb] TD, s  11 ± 3 13 ± 5 11 ± 2 13 ± 3 
Δ[HHb+Mb] τ', s 26 ± 5 29 ± 6 29 ± 8 29 ± 6 
Baseline TOI, %  76.3 ± 5.1† 69.6 ± 3.5 78.4 ± 5.3†* 73.3 ± 4.3* 
TOI A, %  4.5 ± 2.5 6.7 ± 3.7 4.9 ± 2.5* 8.1 ± 4.1* 
TOI τ, s 11 ± 8 12 ± 4 13 ± 4 13 ± 4 
TOI TD, s 12 ± 4 12 ± 4 12 ± 3 13 ± 4 
TOI τ', s 23 ± 5 24 ± 4 25 ± 5 26 ± 6 
Normalized 
Δ[HHb+Mb]/ΔV̇O2 
ratio 1.04 ± 0.12 1.17 ± 0.17 1.01 ± 0.12 1.05 ± 0.14 
 
Values are means ± SD; n, no. of participants. A, amplitude; τ, time constant; TD, 
time delay; τ’, effective response time (τ + TD); [HHb+Mb], deoxygenated 
haemoglobin; TOI, tissue oxygenation index. 
* P < 0.05 vs. Mod A within same diabetes status group (i.e. within controls or within 
Type 2 diabetes). † P < 0.05 vs. participants with type 2 diabetes within same 
condition (i.e. within Mod A or Mod B). 
 
 
 
